Drug development means economics in the end

BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7287.675 (Published 17 March 2001) Cite this as: BMJ 2001;322:675
  1. Stephen Senn (stephens@public-health.ucl.ac.uk), professor of pharmaceutical and health statistics
  1. University College London, London WC1E 6BT

    EDITOR—Garattini and Liberati state, “Millions of people suffer from tropical diseases (malaria, leprosy, schistosomiasis), and yet no one designs realistic strategies to tackle them.”1 But surely the authors are being either naive or disingenuous if they think that the cure for this is to take the responsibility for drug development from those who answer to Wall Street to those who answer to Brussels. Would we not still see breast cancer, heart …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial